Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

David Seymour, New Zealand’s Associate Minister for Health, told reporters that the new policy, which allows a single ...

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

Psilocybin, a psychedelic compound once primarily known as a party drug, is increasingly being recognised for its medical ...

WELLINGTON, New Zealand - New Zealand on Wednesday approved the medicinal use of psilocybin, a hallucinogenic compound ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

New Zealand has approved the medicinal use of psilocybin, a hallucinogenic compound found in magic mushrooms, to treat ...